To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CHST14TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
141 supporting clones for gene CHST14 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_130468.3   .a-u 1 to 2196 1 to 2196 exact RefSeq, AAA   2196/2196
(100 %)
0 diff
(100 %id)
CR997569 T-Lymphocytes .a-u 1 to 275 1 to 275   tiling clone,   275/276
(99 %)
2 diff
(99.3 %id)
AB066595   .a-u 38 to 2196 1 to 2159 exact tiling clone, AAA   2159/2159
(100 %)
0 diff
(100 %id)
BM462607 leiomyosarcoma, uterus .a-u 51 to 560 146 to 663       518/1347
(38 %)
6 diff
(99.6 %id)
BC049214 Uterus, leiomyosarcoma .a-u 54 to 2194 1 to 2141 exact available from MGC, AAA   2141/2141
(100 %)
0 diff
(100 %id)
CR993378 T-Lymphocytes .a-u 63 to 532 1 to 470       470/470
(100 %)
0 diff
(100 %id)
CN311425 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 70 to 482 1 to 413       413/413
(100 %)
3 diff
(99.3 %id)
DR157672 human embryonic stem cells differentiated toan early endodermal cell type .a-u 85 to 713 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BC053633 Uterus, leiomyosarcoma .a-u 95 to 2196 1 to 2102 exact available from MGC, AAA   2102/2102
(100 %)
0 diff
(100 %id)
CX752822 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a-u 95 to 832 1 to 738     Submitted on the opposite strand 738/738
(100 %)
11 diff
(98.6 %id)
BU507340 leiomyosarcoma, uterus .a-u 96 to 806 1 to 716       716/875
(81 %)
17 diff
(98.1 %id)
AF282905   .a-u 202 to 2196 1 to 1995 exact AAA   1995/1995
(100 %)
9 diff
(99.6 %id)
DR157079 human embryonic stem cells differentiated toan early endodermal cell type .a-u 243 to 900 1 to 658       658/658
(100 %)
0 diff
(100 %id)
AK074739   .a-u 246 to 2196 1 to 1951 R195L E214D available from FLJ,   1951/1951
(100 %)
2 diff
(99.9 %id)
DA730679   .a-u 247 to 914 2 to 668   capped   667/721
(92 %)
6 diff
(99.2 %id)
TI_1948236063   .a-u 248 to 1028 122 to 904   fully sequenced,   783/904
(86 %)
13 diff
(98.6 %id)
CX755624 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a-u 253 to 941 1 to 685     Submitted on the opposite strand 685/831
(82 %)
8 diff
(99.1 %id)
TI_1948235593   .a-u 253 to 1121 132 to 1007       876/1176
(74 %)
26 diff
(97.8 %id)
TI_1948235814   .a-u 253 to 1011 132 to 895       764/1300
(58 %)
15 diff
(98.9 %id)
TI_1948236288   .a-u 253 to 1052 130 to 933       804/1233
(65 %)
6 diff
(99.6 %id)
AF401222   .a-u 254 to 2196 1 to 1943 exact AAA   1943/1943
(100 %)
0 diff
(100 %id)
EL734515 mixed .a-u 254 to 867 1 to 614       614/614
(100 %)
0 diff
(100 %id)
TI_1948236287   .a-u 254 to 771 140 to 662       523/1405
(37 %)
37 diff
(97.4 %id)
CX786085 human embryonic stem cells .a-u 273 to 1016 1 to 744       744/744
(100 %)
0 diff
(100 %id)
AA310841   .a-u 317 to 618 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
AY358446   .a-u 357 to 2196 1 to 1840       1840/1840
(100 %)
0 diff
(100 %id)
BG331292 large cell carcinoma, lung .a-u 366 to 1002 1 to 636   available from MGC,   636/935
(68 %)
20 diff
(97.9 %id)
BG331143 large cell carcinoma, lung .a-u 366 to 1024 1 to 652       652/943
(69 %)
33 diff
(96.6 %id)
BG468308 adenocarcinoma cell line, colon .a-u 366 to 1152 1 to 788       788/793
(99 %)
36 diff
(95.5 %id)
BC023653 Lung, large cell carcinoma .a-u 367 to 2196 1 to 1830   available from MGC, AAA   1830/1830
(100 %)
0 diff
(100 %id)
DA863850 placenta .a-u 384 to 946 2 to 565   capped   564/565
(99 %)
2 diff
(99.7 %id)
CN311426 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 400 to 757 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
TI_1948235594   .a-u 452 to 1387 1072 to 125       948/1406
(67 %)
0 diff
(100 %id)
BM802086 duodenal adenocarcinoma, cell line, small intestine .a-u 528 to 1082 19 to 582       564/902
(62 %)
14 diff
(98.5 %id)
BX371513 Placenta Cot 25-normalized .a-u 530 to 1437 906 to 1       906/908
(99 %)
13 diff
(98.6 %id)
BI710926 insulinoma, Pancreas .a-u 549 to 976 1 to 428       428/428
(100 %)
6 diff
(98.6 %id)
CK903261 insulinoma, Pancreas .a-u 549 to 623 1 to 75       75/75
(100 %)
4 diff
(94.7 %id)
BG826507 muscle, rhabdomyosarcoma .a-u 551 to 1285 1 to 728       728/728
(100 %)
13 diff
(98.3 %id)
BG829203 muscle, rhabdomyosarcoma .a-u 551 to 1462 1 to 913       913/913
(100 %)
21 diff
(97.7 %id)
DR006169 Prostate .a-u 585 to 1138 1 to 554       554/554
(100 %)
11 diff
(98.1 %id)
BF130137 hypernephroma, Kidney .a-u 666 to 1285 1 to 611       611/762
(80 %)
22 diff
(97.2 %id)
CX781007 human embryonic stem cells .a-u 698 to 1519 4 to 825       822/825
(99 %)
5 diff
(99.4 %id)
BM803102 duodenal adenocarcinoma, cell line, small intestine .a-u 710 to 1500 1 to 796       796/1049
(75 %)
15 diff
(98.6 %id)
BG674447 skin .a-u 716 to 1497 1 to 788       788/788
(100 %)
15 diff
(98.1 %id)
CN311427 embryonic stem cells, cell lines H1, H7, andH9 .a-u 721 to 1460 1 to 741       741/741
(100 %)
1 diff
(99.9 %id)
BQ447574 Knee, Osteoarthritic Cartilage .a-u 725 to 1166 568 to 125   AAA   444/551
(80 %)
0 diff
(100 %id)
CX780866 human embryonic stem cells .a-u 740 to 1541 1 to 802       802/802
(100 %)
0 diff
(100 %id)
BP330787 rectum .a-u 753 to 1330 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BC009883 Placenta, choriocarcinoma .a-u 797 to 2196 1 to 1400   available from MGC, AAA   1400/1400
(100 %)
0 diff
(100 %id)
BE902594 choriocarcinoma, placenta .a-u 814 to 1605 1 to 781       781/987
(79 %)
31 diff
(96.9 %id)
BE902668 choriocarcinoma, placenta .a-u 816 to 1075 1 to 260       260/260
(100 %)
0 diff
(100 %id)
BE902912 choriocarcinoma, placenta .a-u 820 to 1605 1 to 777   available from MGC,   777/965
(80 %)
22 diff
(97.8 %id)
R35261 whole brain .a-u 835 to 1329 1 to 499       499/501
(99 %)
12 diff
(97.7 %id)
BE908526 epithelioid carcinoma, Pancreas .a-u 915 to 1654 1 to 741       741/882
(84 %)
24 diff
(97.3 %id)
CD636076   .a-u 937 to 1346 1 to 405       405/405
(100 %)
12 diff
(97.1 %id)
CV815036 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a-u 938 to 1662 1 to 725       725/725
(100 %)
0 diff
(100 %id)
BU158058 ductal carcinoma, cell line, Pancreas .a-u 951 to 1812 21 to 897       877/930
(94 %)
53 diff
(94.4 %id)
BU149419 ductal carcinoma, cell line, Pancreas .a-u 956 to 1840 1 to 889       889/901
(98 %)
41 diff
(95.5 %id)
BU145171 ductal carcinoma, cell line, Pancreas .a-u 958 to 1522 1 to 569       569/987
(57 %)
11 diff
(98.9 %id)
BM724090 eye, fetal eye .a-u 959 to 1520 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CX782472 human embryonic stem cells .a-u 969 to 1799 1 to 831       831/831
(100 %)
0 diff
(100 %id)
TI_1948236064   .a-u 998 to 1392 524 to 119   fully sequenced,   406/524
(77 %)
5 diff
(99.1 %id)
BQ270871 insulinoma, Pancreas .a-u 1028 to 1460 1 to 433       433/433
(100 %)
6 diff
(98.7 %id)
CN485282 eye .a-u 1047 to 1178 1 to 132       132/132
(100 %)
0 diff
(100 %id)
CX785410 human embryonic stem cells .a-u 1050 to 1789 1 to 740       740/740
(100 %)
0 diff
(100 %id)
W94722 heart .a-u 1086 to 1598 1 to 514       514/514
(100 %)
7 diff
(98.7 %id)
BX377837 Placenta Cot 25-normalized .a-u 1120 to 2149 1034 to 9       1026/1078
(95 %)
32 diff
(97.1 %id)
BF881634 lung_tumor .a-u 1143 to 1520 1 to 377       377/377
(100 %)
6 diff
(98.5 %id)
AA337988 endometrium .a-u 1195 to 1422 12 to 239       228/239
(95 %)
6 diff
(97.5 %id)
CD636072   .a-u 1201 to 1843 1 to 640       640/640
(100 %)
8 diff
(98.8 %id)
CD636073   .a-u 1201 to 1623 1 to 423       423/423
(100 %)
5 diff
(98.9 %id)
CD636071   .a-u 1210 to 1961 772 to 17       756/772
(97 %)
0 diff
(100 %id)
CD636074   .a-u 1223 to 1957 734 to 1       734/734
(100 %)
3 diff
(99.6 %id)
AW361313 colon .a-u 1260 to 1899 654 to 14       641/654
(98 %)
0 diff
(100 %id)
CD636075   .a-u 1318 to 1680 369 to 4       366/369
(99 %)
0 diff
(100 %id)
AA039240 uterus .a-u 1360 to 1748 9 to 402   fully sequenced,   394/402
(98 %)
7 diff
(98.3 %id)
BG911497 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 1396 to 2137 22 to 770       749/772
(97 %)
21 diff
(97.3 %id)
BG674587 skin .a-u 1401 to 2194 1 to 803       803/881
(91 %)
22 diff
(97.6 %id)
AW401412 lymph .a-u 1409 to 1557 1 to 149       149/149
(100 %)
9 diff
(94.0 %id)
AA331160   .a-u 1412 to 1786 1 to 380       380/380
(100 %)
5 diff
(98.7 %id)
TI_149290581   .a-u 1421 to 2196 868 to 98   AAA   771/929
(82 %)
11 diff
(98.9 %id)
BG105130 adrenal cortex carcinoma, cell line, adrenal gland .a-u 1446 to 2128 1 to 676       676/676
(100 %)
9 diff
(98.7 %id)
TI_149314054   .a-u 1447 to 2198 853 to 109       745/1033
(72 %)
0 diff
(100 %id)
CN311424 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 1464 to 2192 13 to 742       730/744
(98 %)
2 diff
(99.8 %id)
BI772156 pooled lung and spleen .a-u 1464 to 2198 1 to 735       735/741
(99 %)
3 diff
(99.6 %id)
TI_57178928   .a-u 1464 to 2198 27 to 761       735/767
(95 %)
3 diff
(99.7 %id)
BF248109 hypernephroma, Kidney .a-u 1474 to 2145 1 to 666       666/834
(79 %)
57 diff
(93.2 %id)
BI087959 cervix .a-u 1498 to 2204 1 to 707       707/715
(98 %)
13 diff
(98.2 %id)
BM973556 lung .a-u 1518 to 2196 695 to 17   AAA   679/679
(100 %)
4 diff
(99.5 %id)
BQ369036 placenta_normal .a-u 1531 to 1806 1 to 269       269/280
(96 %)
18 diff
(93.6 %id)
BQ369235 placenta_normal .a-u 1531 to 1806 1 to 269       269/280
(96 %)
18 diff
(93.6 %id)
BQ021169 lung, Metastatic Chondrosarcoma .a-u 1534 to 2196 679 to 17   AAA   663/664
(99 %)
0 diff
(100 %id)
BM988613 lung, Metastatic Chondrosarcoma .a-u 1534 to 2196 677 to 17   AAA   661/665
(99 %)
2 diff
(99.7 %id)
TI_154019484   .a-u 1534 to 2196 756 to 94   AAA   663/710
(93 %)
3 diff
(99.6 %id)
CA438002 lung, Metastatic Chondrosarcoma .a-u 1534 to 2196 681 to 19   AAA   663/679
(97 %)
3 diff
(99.6 %id)
BQ128065 insulinoma, Pancreas .a-u 1543 to 1672 1 to 130   fully sequenced,   130/130
(100 %)
5 diff
(96.2 %id)
BF090955 ovary .a-u 1568 to 1804 1 to 237       237/237
(100 %)
3 diff
(98.8 %id)
W24732 lung .a-u 1578 to 1981 1 to 408       408/454
(89 %)
9 diff
(98.1 %id)
BG113157 Bone, osteosarcoma, cell line .a-u 1578 to 2197 1 to 621   AAA   621/621
(100 %)
6 diff
(99.1 %id)
CX780937 human embryonic stem cells .a-u 1586 to 2196 635 to 25   AAA   611/611
(100 %)
11 diff
(98.2 %id)
BG820883 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 1599 to 2206 1 to 612       612/675
(90 %)
10 diff
(98.6 %id)
BE328831 carcinoid, lung .a-u 1611 to 2151 1 to 541     Submitted on the opposite strand 541/541
(100 %)
3 diff
(99.5 %id)
BQ017908 lung, Metastatic Chondrosarcoma .a-u 1612 to 2196 602 to 17   AAA   586/592
(98 %)
2 diff
(99.7 %id)
BQ017945 lung, Metastatic Chondrosarcoma .a-u 1612 to 2196 601 to 17   AAA   585/591
(98 %)
1 diff
(99.9 %id)
TI_154135815   .a-u 1631 to 2194 683 to 109       575/799
(71 %)
0 diff
(100 %id)
BQ128330 insulinoma, Pancreas .a-u 1642 to 2174 533 to 1   fully sequenced,   533/533
(100 %)
0 diff
(100 %id)
DB362601   .a-u 1647 to 2196 550 to 1       550/550
(100 %)
9 diff
(98.4 %id)
CB305853 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 1659 to 2196 555 to 19   AAA   537/537
(100 %)
14 diff
(97.4 %id)
AL040909 testis .a-u 1660 to 2169 510 to 1       510/510
(100 %)
0 diff
(100 %id)
BX090140 whole brain .a-u 1677 to 2196 536 to 15   AAA   522/522
(100 %)
2 diff
(99.7 %id)
BQ270626 insulinoma, Pancreas .a-u 1723 to 2196 489 to 16   AAA   474/474
(100 %)
0 diff
(100 %id)
BQ018416 lung, Metastatic Chondrosarcoma .a-u 1724 to 2196 489 to 17   AAA   473/473
(100 %)
0 diff
(100 %id)
AW043726 pooled .a-u 1726 to 2196 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
AA039350 uterus .a-u 1727 to 2196 473 to 1   fully sequenced,   473/473
(100 %)
5 diff
(99.0 %id)
AI871093 anaplastic oligodendroglioma, brain .a-u 1730 to 2198 471 to 3       469/471
(99 %)
0 diff
(100 %id)
EB643244   .a-u 1738 to 2125 405 to 18       388/428
(90 %)
0 diff
(100 %id)
EB643245   .a-u 1738 to 2125 21 to 408       388/420
(92 %)
1 diff
(99.8 %id)
AI857485 anaplastic oligodendroglioma, brain .a-u 1743 to 2191 460 to 12       449/460
(97 %)
0 diff
(100 %id)
TI_151733188   .a-u 1745 to 2194 538 to 89   AAA   450/972
(46 %)
0 diff
(100 %id)
BX373104 Placenta Cot 25-normalized .a-u 1746 to 2188 441 to 1       441/456
(96 %)
22 diff
(95.2 %id)
BQ188838 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a-u 1746 to 2201 1 to 456   fully sequenced, AAA   456/456
(100 %)
5 diff
(99.0 %id)
AI654017 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 1747 to 2196 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
AA609172   .a-u 1759 to 2197 439 to 1       439/439
(100 %)
5 diff
(98.9 %id)
AI610359 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a-u 1771 to 2196 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA922082 adenocarcinoma, colon .a-u 1783 to 2196 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
AI363492 anaplastic oligodendroglioma, brain .a-u 1787 to 2203 420 to 4       417/420
(99 %)
0 diff
(100 %id)
AW019869 cochlea, ear .a-u 1787 to 2197 11 to 421   AAA   411/421
(97 %)
5 diff
(98.9 %id)
AA833529   .a-u 1796 to 2198 405 to 3       403/405
(99 %)
0 diff
(100 %id)
BI711377 insulinoma, Pancreas .a-u 1799 to 2194 410 to 15   AAA   396/396
(100 %)
0 diff
(100 %id)
EC494867 Prostate .a-u 1804 to 1910 106 to 1       106/106
(100 %)
5 diff
(95.3 %id)
AA737909 pooled germ cell tumors .a-u 1819 to 2196 378 to 1       378/378
(100 %)
0 diff
(100 %id)
AA826460 carcinoid, lung .a-u 1820 to 2198 405 to 25       381/405
(94 %)
0 diff
(100 %id)
AI536808 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a-u 1825 to 2197 374 to 1       374/378
(98 %)
8 diff
(97.9 %id)
R50932 whole brain .a-u 1840 to 2196 393 to 26   AAA   368/397
(92 %)
14 diff
(96.5 %id)
AI497959 anaplastic oligodendroglioma, brain .a-u 1866 to 2196 352 to 22   AAA   331/331
(100 %)
2 diff
(99.4 %id)
CX780806 human embryonic stem cells .a-u 1869 to 2196 362 to 34   AAA   329/329
(100 %)
23 diff
(93.1 %id)
N57831 liver and spleen .a-u 1877 to 2196 340 to 14   AAA   327/327
(100 %)
11 diff
(96.7 %id)
BE350192 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a-u 1879 to 1942 64 to 1       64/66
(96 %)
2 diff
(97.0 %id)
AW088881 ovary, tumor, 5 pooled (see description) .a-u 1899 to 2196 298 to 1       298/300
(99 %)
4 diff
(98.7 %id)
AI686320 Prostate .a-u 1904 to 2196 306 to 14   AAA   293/293
(100 %)
1 diff
(99.7 %id)
AA588757 colon, colon tumor .a-u 1916 to 2195 280 to 1       280/280
(100 %)
6 diff
(97.9 %id)
AI364550 anaplastic oligodendroglioma, brain .a-u 1933 to 2198 273 to 8       266/273
(97 %)
0 diff
(100 %id)
AI685789 Prostate .a-u 1949 to 2198 250 to 1       250/250
(100 %)
1 diff
(99.6 %id)
CK301195 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a-u 1954 to 2194 259 to 19   fully sequenced, AAA   241/241
(100 %)
0 diff
(100 %id)
BF109505 pooled .a-u 1981 to 2197 217 to 1       217/217
(100 %)
2 diff
(99.1 %id)
AI184432 heart .a-u 1988 to 2198 215 to 5       211/215
(98 %)
0 diff
(100 %id)
AI217275 pooled .a-u 2027 to 2198 179 to 8       172/179
(96 %)
0 diff
(100 %id)
AI468096 anaplastic oligodendroglioma, brain .a-u 2035 to 2196 192 to 32   AAA   161/164
(98 %)
3 diff
(98.2 %id)
AI914850 ovary, tumor, 5 pooled (see description) .a-u 2051 to 2196 146 to 1       264/289
(91 %)
13 diff
(95.6 %id)
EC443282 Prostate .a-u 2074 to 2193 120 to 1       120/120
(100 %)
0 diff
(100 %id)
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes DC